Citation: M. Shimakage et T. Sasagawa, Detection of Epstein-Barr virus-determined nuclear antigen-2 mRNA by in situ hybridization, J VIROL MET, 93(1-2), 2001, pp. 23-32
Authors:
Shimakage, M
Sasagawa, T
Kawahara, K
Yutsudo, M
Kusuoka, H
Kozuka, T
Citation: M. Shimakage et al., Expression of Epstein-Barr virus in cutaneous T-Cell lymphoma including mycosis fungoides, INT J CANC, 92(2), 2001, pp. 226-231
Authors:
Sasagawa, T
Shimakage, M
Nakamura, M
Sakaike, J
Ishikawa, H
Inoue, M
Citation: T. Sasagawa et al., Epstein-Barr virus (EBV) genes expression in cervical intraepithelial neoplasia and invasive cervical cancer: A comparative study with human papillomavirus (HPV) infection, HUMAN PATH, 31(3), 2000, pp. 318-326
Citation: M. Shimakage et al., Proper use of serum antibody titres against Epstein-Barr virus in nasopharyngeal carcinoma: IgA/virus capsid antigen for diagnosis and EBV-related nuclear antigen-2 for follow-up, ACT OTO-LAR, 120(1), 2000, pp. 100-104
Authors:
Shimakage, M
Kimura, M
Yanoma, S
Ibe, M
Yokota, S
Tsujino, G
Kozuka, T
Dezawa, T
Tamura, S
Ohshima, A
Yutsudo, M
Hakura, A
Citation: M. Shimakage et al., Expression of latent and replicative-infection genes of Epstein-Barr virusin macrophage, ARCH VIROL, 144(1), 1999, pp. 157-166
Authors:
Shimakage, M
Sasagawa, T
Yoshino, K
Yutsudo, M
Kimura, M
Yamamoto, N
Yanoma, S
Citation: M. Shimakage et al., Expression of Epstein-Barr virus in mesopharyngeal and hypopharyngeal carcinomas, HUMAN PATH, 30(9), 1999, pp. 1071-1076